Who
Philip Ferneau
Director
Company insider
Files Form 4 as: Director, Compass Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 1
- Sells
- 0
- Bought
- $1.6M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Jun 2020
- Last trade
- 2 Jan 2026
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 5 Jan 2026 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 11 Feb 2025filed 13 Feb 2025 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 9 Feb 2024filed 14 Feb 2024 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 8 Feb 2023filed 9 Feb 2023 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 18 Feb 2022filed 23 Feb 2022 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 19 Jun 2020filed 23 Jun 2020 | CMPX Compass TherapeuticsBiotechnology | SEC FORM 4 Bought | $320K64,066 at $5.00 | filing |
| 19 Jun 2020filed 23 Jun 2020 | CMPX Compass TherapeuticsBiotechnology | SEC FORM 4 Bought | $1.3M250,000 at $5.00 | filing |
News
Compass Therapeutics, Inc. (NASDAQ:CMPX) Stock Has Average Target Price of $10.21CMPX · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Philip Ferneau; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.